The PCSK9i Inhibitor Evolocumab - a Surgical Trial of Pharamcodynamics and Kinetics Evaluation
NCT04937413
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Malignant Glioma
Glioblastoma
Interventions
DRUG:
Evolocumab
Sponsor
Duke University